Tissue Diagnostic Market by Product Type, Technology, Disease, and End User - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017–2025

Tissue diagnosis is important tool in diagnosis, monitoring, and management of different types of cancer conditions. Recognition of sign and symptoms of disease are done through biopsy, a process of taking sample from region of interest such as skin, tissue or tumor for further diagnosis. Biopsy are primarily done to look for cancer detection or to detect rejection of transplanted organ draft.

Biopsy is done to identify likely cause of cancerous and non-cancerous tissue, which are unable to detect through CT-scan or X-rays. Depending on area of sample collection various biopsy procedures are done such as endoscopic biopsy, bone marrow biopsy, skin biopsy, kidney biopsy, liver biopsy, and prostate biopsy. Furthermore biopsy can be done using needle biopsy, CT guided biopsy, Ultrasound biopsy, and surgical biopsy for the tissue diagnostic. According to the American journal of Nephrology, 2015, Australia has the highest numbers of annual renal biopsy rates (215 persons/million person/year) followed by the Finland (176 persons/million person/year) and U.S. (175 persons/million person/year). The increased numbers of biopsy procedure likely to fuel the growth of tissue diagnostic market, in near future.

Request to download and view Sample Report: https://www.coherentmarketinsights.com/insight/request-sample/1112

Rising prevalence of different cancer incidences is major driving factor boosting the tissue diagnostic market. According to American cancer Society (ACS), 1.6 million new cases of cancer diagnosed in the U.S., in 2016. In addition, increase research funding in cancer treatment and growing healthcare expenditure likely to show gradual rise in tissue diagnostic market. National Cancer Institute, in 2015, spends US$ 4,480 million on various types of cancer research which includes breast cancer, colorectal cancer, cervical cancer, liver cancer, lung cancer, leukemia, ovarian cancer and uterine cancer.

Tissue diagnostic market taxonomy:

By Product Type:

• Instruments
• Tissue processors
• Microtomes
• Cryostats
• Slide warmers
• Paraffin dispenser
• Biological microscopes
• Embedded center modules
• Strainers
• Consumables
• Stains
• Paraffin
• Cassettes
• Autopsy & dissection
• Slides

By Technology:

• In situ hybridization
• Digital pathology
• Immunohistochemistry
• Tissue microarray
• Special staining

By Disease:

• Breast cancer
• Lymphoma cancer
• Gastric cancer
• Prostate cancer

By End user:

• Research laboratories
• Hospitals
• Contract research organizations

Rise in the prevalence of cancer incidences to boost the tissue diagnostic market

According to the United States Cancer statistics report published in 2014 by Centers of Disease Control and Prevention (CDC), between 1999 and 2014, more than 1600 people a day, died due to the cause of cancer. Although screening tests helps to detect cancer condition at early stage, data from Healthy People 2020, an initiative form Department of Health and Human Services, reveals that screening rate is still below the national targets set. Combined data collected from CDC and National cancer institute (NCI) focus on the top 3 cancer incidences in male and female. In male prostate cancer incidence are higher, while in females breast cancer are most dominated, followed by lung and colon cancer respectively in both male and female.

Browse Research Report At: https://www.coherentmarketinsights.com/ongoing-insight/tissue-diagnostic-market-1112

New and advanced methods of tissue diagnosis favors the market growth

Innovation in tissue diagnostic process for the efficient diagnostic testing such as Fluorescence in situ hybridization (FISH), Immunohistochemistry (IHC) and In situ hybridization (ISH) raises the opportunity to grow tissue diagnostic market in future. In September 2017, researchers at the University of Texas, developed a new way of diagnosis by creating pen named as “MasSpec Pen”, which is handheld devices able to distinguish healthy tissue and tumor tissue in just 10 seconds, more than 150 times quicker than existing technology. These new tool provides improvement in cancer treatment and minimizes the chances of recurrence by offering precise diagnostic information, which eventually favors the growth in tissue diagnostic market.

Key players operated in the tissue diagnostic market are Biocare Medical, Agilent technologies, Thermo Fisher Scientific, Sigma-Aldrich, Roche Diagnostics, Danaher corp., Biogenex Laboratories, Life Technologies and Abbott laboratories.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Pharmacovigilance Market, by Clinical Trial, Types Of Reporting, Service Provider, and End User - Trends, Outlook, and Opportunity Analysis, 2025

Pharmacovigilance is a study of safety and efficacy of a medical product or drug. It is a science associated with the collection, detection, assessment, and prevention of adverse effects related with the medical product or drug. The role of pharmacovigilance is to analyze the side effects of the drug and determine the adverse effects, negatively affecting the drug’s efficacy and vice-versa. Pharmacovigilance comprises drug discovery and development, preclinical research, clinical research, and post marketing surveillance. It traces every phase of a drug cycle from preclinical development to post-market surveillance. Increasing prevalence of adverse drug reaction and implementation of safety regulations by government regulatory bodies is expected to fuel growth of the pharmacovigilance market over the forecast period.

Request to download and view Sample Report: https://www.coherentmarketinsights.com/insight/request-sample/1047

Growing prevalence of adverse drug reactions is expected to fuel pharmacovigilance market growth over the forecast period

Growing prevalence of adverse reactions caused by drugs, has influenced the pharmaceutical and biotechnological industries to adapt practices of pharmacovigilance, is in turn, expected to fuel growth of the market for pharmacovigilance in the near future.

Government regulatory bodies such as the U.S. Food and Drug Administration (U.S.-FDA) and European Medicines Evaluation Agency (EMEA) have formulated safety regulations to ensure manufacture of safe drugs and evaluation of its after-effects on patients. These regulations have to be followed by pharmaceutical and biotechnological companies, in turn, fueling demand for pharmacovigilance. Moreover, increasing R&D in the drug sector is further expected to propel growth of the pharmacovigilance market.

Global Pharmacovigilance Market Taxonomy

On the basis of clinical trial, the global pharmacovigilance market in segmented into:

• Preclinical Studies
• Phase I
• Phase II
• Phase III
• Phase IV or Post Marketing Surveillance

On the basis of types of reporting, the global pharmacovigilance market in segmented into:

• Spontaneous Reporting
• Targeted Spontaneous Reporting
• Cohort Event Monitoring
• Intensified ADR Reporting
• EHR Mining

On the basis of service provider, the global pharmacovigilance market in segmented into:

• Contract Outsourcing
• In-house

On the basis of end user, the global pharmacovigilance market in segmented into:

• Medical Device
• Biotechnological
• Pharmaceutical

Europe is expected to hold a dominant position in the global pharmacovigilance market, due to introduction of new legislation in European Union

Europe is expected to hold a dominant position in the global pharmacovigilance market, over the forecast period. This is mainly due to introduction of new legislations in European Union in 2012, which ensures good vigilance practices for pharmaceutical companies and medicines regulators.. According to National Center for Biotechnology Information, in 2016, Europe accounted for high incidence of adverse drug reactions, around 5% of all hospital admissions were due to drug reactions, which caused around 197,000 deaths in EU. Increasing prevalence of adverse drug reactions and introduction new legislation has influenced adoption of pharmacovigilance among companies, in turn, fueling the market growth in the region. North America is expected to hold the second-largest market for pharmacovigilance due to increasing development of new drugs and growth in research and development activities of pharmaceutical and biotechnology in the U.S.

Browse Research Report At: https://www.coherentmarketinsights.com/ongoing-insight/pharmacovigilance-market-1047

Key Players in the Pharmacovigilance Market

PharmaLex, a development consulting and affairs group has collaborated with Volv to boost its pharmacovigilance business. Key players operating in the global pharmacovigilance market include Accenture, Cognizant, PAREXEL International Corporation, IBM Corporation, Clinquest Group B.V., Wipro Ltd, Oracle Corporation, Foresight Group International AG, TAKE Solutions Ltd, and United BioSource Corporation.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Microfluidic Market to Surpass US$ 13.8 Billion Threshold by 2025

The Global Microfluidic Market, by Material Type (Silicon-Based Microfluidic, Glass-Based Microfluidic, Polymer-Based Microfluidic, and Others), by Application (In Vitro Diagnostic Devices, Drug Delivery Devices and Monitoring Devices), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) was valued at US$ 2.8 billion in 2016 and is projected to exhibit a CAGR of 19.4% over the forecast period (2017–2025), as highlighted in a new report published by Coherent Market Insights. Increasing adoption of microfluidic technology to produce miniaturized microfluidic chips used in molecular diagnosis and analysis, is expected to boost growth of the microfluidic market. For instance, in March 2016, 908 Devices Inc. launched, ZipChip, a microfluidic device that provides high quality separation possibilities to mass spectroscopy enabling fast analysis for a broader range of biomolecules.

Request to download and view Sample Report: https://www.coherentmarketinsights.com/insight/request-sample/1086

Advancement in microfluidics technology such as lab-on-a-chip is expected to propel growth of the market

Advancement in microfluidic technology such as sample droplet production technique, microfluidic sensors, lab-on-a-chip, microfluidic enabled microscope, and microfluidic valve controller helps to further augment growth of the microfluidic market. Moreover technology advancement in microfluidic saves the time, eliminate the need of expensive laboratory robots and reduce the risk of sample loss and contamination. For instance, in February 2017, researchers at the Stanford University School of Medicine have developed a relatively cheap and reusable diagnostic lab-on-a-chip for medical diagnostic application, which is expected to enhance the diagnostic capabilities and would be a highly feasible option in emerging economies.

Rising adoption of microfluidic technology in drug delivery systems is expected to accelerate demand for microfluidics

Controlled drug delivery system deliver the drug at target sites, in desired quantity, and on time thus, enhancing drug efficiency, bioavailability, and pharmacokinetics while maintaining minimum side effects. Microfluidic-based devices are adopted significantly for micro and nano-scale drug delivery, maintaining the physiochemical characteristics of drug, at the target location. For instance, researchers at the Massachusetts Eye and Ear Infirmary, Harvard Medical School and Charles Stark Draper Laboratory in Massachusetts developed microfluidic based automated micropump device for direct delivery of drugs into the perilymph fluid within the cochlea- an auditory portion of the inner ear.

Key players in the microfluidic market are emphasizing on introducing innovative solutions based on microfluidic technology for a wide range of applications. For instance, in November 2017, Dolomite Bio introduced Nadia- a single-cell platform for single-cell RNA sequencing. Nadia is droplet microfluidic based instrument that can generate 6,000 single-cell libraries per sample in just 15 minutes. It also aids researchers to run multiple samples parallelly. Dolomite Bio combines the microfluidic technology with automated temperature control and cell/bead agitation in single instrument that delivers highly precise and reliable results. OPKO Health, Inc., in November 2017 submitted the Premarket Approval (PMA) application to US FDA for Claros 1 immunoassay analyzer. Claros 1 immunoassay analyzer is a diagnostic instrument system, which uses microfluidics technology to provide quick and quantitative blood test result in just 10 minutes by eliminating the need of external reagent, instrument calibration and maintenance.

Browse 30 Market Data Tables and 35 Figures spread through 190 Pages and in-depth TOC on “Microfluidic Market”- Global Forecast to 2025

To know the latest trends and insights prevalent in the Microfluidic market, click the link below: https://www.coherentmarketinsights.com/market-insight/microfluidic-market-1086

Key Takeaways of the Microfluidic Market:

• The global microfluidic market is expected to exhibit a CAGR of 19.4% over the forecast period, owing to the increased cardiovascular disease. For instance, in 2014, cardiovascular disease was the leading cause of death in China, accounting for around 42.60% and 44.52% of all deaths in rural and urban areas respectively. The other factors effecting the rise in microfluidic market are, increasing geriatric population and advancement in POC testing devices.
• Among materials, the polymer-based microfluidic material segment is expected to account for major share over the forecast period. This is attributed to cost-effective, simple, and disposal advantage of these materials for total analysis system and lab-on-a-chip (LOC) devices.
• Among application, the drug delivery devices segment is expected to be dominant in the microfluidic market over the forecast period, owing to factors such as safe, user-friendly, and controlled drug delivery of biomolecules of the systems.
• Some of the major players operating in the global microfluidic market are Abbott Laboratories, Agilent Technologies, Thermo Fisher Scientific Inc., Qiagen N.V., Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd., Fluidigm Corporation, Danaher Corporation, PerkinElmer Inc., Siemens Healthcare GmbH, and Micronit Microfluidic BV

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Brain Health Devices Market, By Product Type, Application - Global Trends, and Forecast 2017 - 2025

Brain health devices are used in the treatment of neurological disorders such as Alzheimer disease and other dementias, epilepsy, cerebrovascular diseases, including stroke, migraine, and other headache disorders, Parkinson’s disease, multiple sclerosis, neuroinfections, brain tumors, traumatic disorders of the nervous system due to head trauma and neurological disorders as a result of malnutrition. Neurological disorders may also occur due to various infections such as viral infection (Zika virus), bacterial infection (Neisseria meningitides), and fungal infection (Cryptococcus). According to the World Health Organization (WHO), in 2016, around 450 millions of people were affected by neurological disorders across the world. Around 50 million people were reported to be suffering from epilepsy across the globe and over 6 million people die due to stroke each year. Brain health devices such as CT scan, MRI, EEG, MEG, Transcranial Doppler (TCD) devices are commonly used to monitor brain activity.

Request to download and view Sample Report: https://www.coherentmarketinsights.com/insight/request-sample/1095

Rising prevalence of Alzheimer’s disease is expected to boost market growth

The major factor contributing to growth of the brain health devices market is the rising number of Alzheimer’s cases. For instance, According to the Alzheimer’s Association, in 2017, over 5 million people are estimated to be suffering from Alzheimer’s disease, which is also reported to be the sixth-leading cause of death in the U.S. Furthermore, growing geriatric population, rising number of traumatic brain injury cases, and rampant advancements in technology such as brain biomarkers, gene therapy, stem cell therapy and smart brain prosthetics are contributing to growth of the brain health devices market. Furthermore, diagnosis and treatment neurodegenerative diseases through the microbiome and neuroimaging techniques further augments market growth. However, high costs of these devices are responsible for hindering market growth.

Brain Health Devices Market Taxonomy:

The global brain health devices market is segmented on the basis of devices, application, end user, and geography

On the basis of devices, the global brain health devices market is segmented into

• Magnetic Resonance Imaging
• Magneto Encephalogram
• Computed Tomography
• Electro Encephalogram
• Intracranial Pressure Monitors
• Transcranial Doppler Devices

On the basis of application, the global brain health devices market is segmented into

• Stroke
• Epilepsy
• Headache Disorders
• Dementia
• Parkinson’s disease
• Traumatic Brain Injuries
• Dyslexia
• Others

On the basis of end user, the global brain health devices market is segmented into

• Hospitals
• Specialty Clinics
• Others

On the basis of region, the global brain health devices market is segmented into North America, Latin America, Europe, Asia pacific, Middle East, and Africa. North America is expected to hold a dominant position in the global brain health devices market, owing to rising number of traumatic brain injury cases in the U.S. For instance, According to the Centers for Disease Control and Prevention in 2013, around 282,000 people were diagnosed with brain injury and around 50,000 people died due to traumatic brain injury. It is estimated to be a major cause of disability and death in the U.S. Furthermore, high adoption of advanced technologies such as Pacifica, Pala-linq, and Spire and Fisher Wallace Stimulator have also contributed to growth of the brain health devices market in the U.S. Moreover, Asia Pacific is expected to be the fastest-growing region in the global brain health devices market.  According to the Journal of Nature, China launched brain imaging factory in 2017 that will help researchers to map neural connectivity for the studies of Alzheimer’s disease to brain inspired artificial intelligence projects.

Browse Research Report At: https://www.coherentmarketinsights.com/ongoing-insight/brain-health-devices-market-1095

FDA approval of the first handheld medical device Ahead 300 launched by BrainScope is expected to propel the brain health devices market

Major players involved in the global brain health devices market include BrainScope Company, Inc., Bio-Signal Group Corp., Cadwell Industries, Inc. Advanced Brain Monitoring, Inc., Compumedics Ltd., Elekta, DePuy Synthes, Electrical Geodesics, Inc., Medtronic, GE Healthcare, MEG International Services Ltd, Natus Medical, Inc., Neurowave Systems Inc., Nihon Kohden Corporation, and Philips Healthcare. The key players are focusing on strategic mergers and acquisitions and development of innovative products. For instance, in 2016, Food and Drug Administration (FDA) approved the first handheld medical device named Ahead 300, launched by BrainScope Company, Inc. for assessing traumatic brain injury.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Hypodermic Needles Market, By Product Type, Application - Global Trends, and Forecast 2017 - 2025

Hypodermic needles are hollow needles that are attached with hypodermic syringes for injecting saline solution or solution containing liquid medicines and drugs. These needles are also useful in extraction of fluids such as blood from the body. Hypodermic needles can be used as disposable as well as reusable needles. The reusable needles must be sterilized before use due to their ability to cause various diseases or infections that might transmit if they are not sterile. Disposable hypodermic needles aids an important role in research environments where sterile conditions are required and it also reduces contamination significantly during inoculation of a sterile substrate. Thus, preventing colonization of airborne pathogens on the needles surface. Hypodermic needles are primarily of two types, which include safety and non-safety hypodermic needles. Safety hypodermic needles are the needles on the safety syringe that can be permanently attached or detachable thus preventing healthcare professional from needle stick injuries. Whereas, non-safety hypodermic needles are the conventional syringe needles, which lack safety mechanisms thereby possessing higher chances of needle stick injuries.

Request to download and view Sample Report: https://www.coherentmarketinsights.com/insight/request-sample/1102

Rising demand for vaccines is expected to boost the hypodermic needles market

The factors that are contributing to the growth of hypodermic needles market are rising demand for intravenous vaccines delivery mode. There are numerous vaccines that are recommended for injection into muscle (intramuscularly) although some are delivered through subcutaneously and intradermally. Furthermore, increasing prevalence of chronic diseases and rising compliance for safety needles so as to curtail the incidences of needle stick injuries are the other factors that are contributing to the growth of hypodermic needles. However, rising incidence of needle stick injuries and risk of infections associated with administering drugs using hypodermic needles are hindering the growth of hypodermic needles market.

Hypodermic Needles Market Taxonomy:

Hypodermic Needles Market is segmented on the basis of Product type, end user, and geography

On the basis of product type, hypodermic needles market is segmented into:

• Safety hypodermic needle
• Passive hypodermic needle
• Retractable hypodermic needle
• Non- retractable hypodermic needle
• Active hypodermic needle
• Retractable hypodermic needle
• Non – retractable hypodermic needle
• Non safety hypodermic needle

On the basis of end user, hypodermic needles market is segmented into:

• Diagnostic Center
• Hospital
• Others

On the basis of region, hypodermic needles market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America is expected to hold a dominant position in the global hypodermic needles market, owing to the launch of new product called SafeTouch Safety Needle in 2016, by Nipro Medical Corporation, which is known to protect the patients from needle stick injuries. Furthermore, Asia Pacific is expected to witness a major traction in the global hypodermic needles market, owing to the conducive policies for the approval of new injectable and increasing technological advancements. For instance, Microdermics in 2017 has developed a novel commercially scalable, low-cost, customizable, metal, hollow, and microneedle platform that provides efficient delivery of vaccines and biologics.

Browse Research Report At: https://www.coherentmarketinsights.com/ongoing-insight/hypodermic-needles-market-1102

The innovative K pack Surshield launched by Terumo Medical Corporation is expected to propel the market growth

The key players in the hypodermic needles market include Albert David, Becton, Connecticut Hypodermics, Retractable Technologies, Novo Nordisk, BD, Covidien, Terumo Medical Corporation, Dickinson, Vygon, Vita Needle Company, Unilife Corporation, Hindustan Syringes & Medical Devices Limited, and Nipro Medical Corporation. The key players are focusing on strategic mergers and acquisition and development of innovative systems. For instance, Terumo Medical Corporation has launched an innovative hypodermic needle known as K-Pack Surshield in 2012, which has an integrated passive sharps protection feature with pre filled syringes. The device is used to allow automated manipulations during the packaging process, which makes it ideal for inclusion and bundling into the secondary packaging of parenteral medication.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Clinical Nutrition Market to Surpass US$ 73.1 Billion Threshold by 2025, on the Back of Increasing Prevalence of Diabetes

The Global Clinical Nutrition Market by Product Type (Infant Nutrition (Milk based, soy-based, Organic, Probiotics/ Prebiotics and Others), Enteral Nutrition (Standard Nutrition, Disease Specific) Parenteral Nutrition (Amino acids, Fats and Carbohydrates), and by Region (North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa) was valued at US$ 42.2 billion in 2016 and is projected to exhibit a CAGR of 6.3% over the forecast period (2017–2025), as highlighted in a new report published by Coherent Market Insights. The major drivers for the global clinical nutrition market includes increasing prevalence of diabetes, cancer, and other chronic and metabolic disorder.

Manufacturers are focusing on innovation and new launches to tap into emerging markets. For instance, in March 2017, B. Braun Medical Ltd launched a new range of nutritionally complete dietary drinks named Nutricomp Drink Plus, which are available in four flavors and are high-energy milkshake supplement that can be prescribed for the dietary management of malnutrition. San Francisco based Before Brands, Inc. in October 2017, launched a new product SpoonfulOne Daily Food Mix-in, which is a daily dietary supplement powder that is made to train the child’s body to get accustomed to foods responsible for 90% of food allergies.

Request to download and view Sample Report: https://www.coherentmarketinsights.com/insight/request-sample/980

Increasing demand for organic clinical nutrition has also led to recent launches of organic clinical nutrition to meet the demand of population. For instance, in March 2017, Garden of Life, the innovator in USDA Organic and Non-GMO Project Verified nutritional products expanded into the sports nutrition arena with the launch of Garden of Life SPORT, which in turn will contribute towards the growth of the clinical nutrition market.

Browse 30 Market Data Tables and 28 Figures spread through 155 Pages and in-depth TOC on Clinical nutrition market  by Product Type (Infant Nutrition (Milk based, soy-based, Organic, Probiotics/ Prebiotics and Others), Enteral Nutrition (Standard Nutrition, Disease Specific) Parenteral Nutrition (Amino acids, Fats and Carbohydrates), and by Region (North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa) - Global Forecast to 2025

In today’s evolving healthcare industry, proper nutrition is the foundation for healthy lives, due to which manufacturers have been developing science-based nutrition products. The manufacturers are also developing products to support patients through all stages of life, from infancy to childhood to adulthood. For instance, Abbott laboratories in 2016, introduced science-based nutrition drinks, Ensure Surgery Immunonutrition Shake and Ensure Pre Surgery Clear Nutrition to help patients recover from surgeries. In 2017, Abbott added a new ingredient (2’-fucosyllactose) found in human breast milk to its Similac Pro-advance and Pro Sensitive infant formulas and linked to demonstrate its benefits for babies via boosting their immune system. In 2015, Fresenius Kabi AG company expanded its presence in the clinical nutrition segment by distributing the three chamber bag (SmofLipid) for parenteral nutrition in more than 65 economies and have also received approval to sell the product in the U.S., which allowed maximum application safety and convenience in everyday use.

Furthermore, Danone in 2015, announced investment of US $278.62 Mn to build a new plant for company’s early life nutrition brands. Nestlé acquired Pamlab, in 2013, which was specialized in medical food and clinical nutrition products for use under medical supervision in the nutritional management of patients with mild cognitive impairment, depression, and diabetic peripheral neuropathy.

To know the latest trends and insights prevalent in the Clinical nutrition market, click the link below: https://www.coherentmarketinsights.com/market-insight/clinical-nutrition-market-980

Key takeaways of the market:

• The global clinical nutrition market is expected to exhibit a CAGR of 3% over the forecast period (2017–2025), owing to the rise in the aging population and premature births. The Asia Pacific region in the global clinical nutrition market is expected to exhibit a high growth rate, in terms of value, over the forecast period.
• Among the product type, infant nutrition segment is expected to exhibit a largest market share as major nutritional need arises from premature births
• The global clinical nutrition market is characterized by market expansion in Asia Pacific, North America, and Europe, which is expected to generate higher market revenue due to increase in prevalence of disabilities.
• Some of the major companies offering clinical nutrition products are Nestle, Fresenius Kabi, Abbott Nutrition, Danone, Baxter Healthcare and B Braun Melsungen AG.

About CMI

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Urology Surgical Instruments Market, By Product Type, Distribution Channel, and Application - Global Trends, and Forecast 2017 - 2025

Urology surgeries are associated with the treatment of urologic disease or dysfunction of male and female urinary tract. Urologic disease or dysfunction in male include bladder control dysfunction, kidney stones, prostate disorders, nephrectomy, pyeloplasty, ureteral reimplants, and urinary retention. According to the National Kidney Foundation (NKF), in 2016, around 121,678 people were waiting for organ transplants in the U.S., out of which 100,791 were waiting for kidney transplants. According to National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), overall prevalence of chronic kidney disease in the U.S. was around 14% in 2016.

Request to download and view Sample Report: https://www.coherentmarketinsights.com/insight/request-sample/1036

The growth of urology surgical instruments market is backed by the rising prevalence of urinary tract infections, kidney diseases, and increasing geriatric population, which opt for the surgical urology procedures. According to the United States Renal data System (USRDS), between 2012 and 2013, there was 3.1% increase in the cumulative number of recipients with kidney transplant. According to the NKF, around 17,107 kidney transplants took place in the U.S. in 2014, moreover approximately 3,000 new patients are added to kidney transplant waiting list each month. According to the National Chronic Kidney Disease 2017 Factsheet, estimated by Centers for Disease Control and Prevention (CDC), around 15% or 30 million geriatric population in the U.S. are reported to have chronic kidney disease (CKD), out of which around 48% people are suffering from severely impaired kidney function. Increased number of geriatric population with diabetics, high blood pressure or people having both are at higher risk of developing CKD, which further may lead to kidney transplant surgery, in turn driving the urology surgical instruments market. According to the CDC, in 2017, approximately 1 in 3 adults having diabetes condition in the U.S., may have any of the chronic kidney disorder.

However, high risk of complications associated with surgical procedures in geriatric patients and increasing cost of urology endoscope and laparoscopic endovision system, are expected to be major restraints for the urology surgical instruments market. According to the data published in National Center for Biotechnology Information (NCBI), U.S. National Library of Medicine, in February 2015, number of geriatric population undergoing urological surgeries showed various surgical complicated infections such as sepsis, mild respiratory insufficiency, and delirium.

Urology Surgical Instruments Market Taxonomy:

On the basis of product type, the global urology surgical instruments market segmented into:

• Cysto sheaths
• Urology endoscope
• Cystoscope
  • Laser cystoscope
  • Rigid cystoscope
  • Flexible cystoscope
• Resectoscope
• Nephroscope
• Pediatric nephroscope
• Ureteroscope
• Flexible ureteroscope
• Rigid ureteroscope
• Laparoscope
• Forceps
• Optical forceps
• Flexible forceps
• Resectoscope electrodes
• Urethrotome
• Cystoscope bridge
• Channel deflector
• Other urology accessories

On the basis of distribution channel, the global urology surgical instruments market segmented into:

• Hospitals
• Surgical Centers

On the basis of application, the global urology surgical instruments market segmented into:

• Kidney stone
• Urinary tract infections
• Urinary bladder disorder
• Chronic kidney disease
• Benign prostatic hyperplasia
• Other applications

Browse Research Report At: https://www.coherentmarketinsights.com/ongoing-insight/urology-surgical-instruments-market-1036

Continuous development in robotic-assisted surgeries to drive the market growth

Minimally invasive robotic-assisted surgeries are found to be effective in treating various urological disease and dysfunction, which include kidney cancer, prostate cancer, kidney dysfunction, urinary tract disorders, and congenital abnormalities in children. Loyola medicine, an academic medical center of Loyola University Health System, in 2017, developed a RoboLog, a web-based robotic experience logging system, which records surgical process progression, experience, and provides feedback during robotic assisted surgery. According to the study published in Journal of Surgical Education 2017, RoboLog, was successfully completed and piloted on 310 urologic robotic surgeries. RoboLog developed a reporting structure where surgeon can view statistics like log time and median time for each step involved in robotic surgery.

Titan Medical Inc. in 2017, announced the successful completion of world’s first gynecologic, urological, and colorectal single port robotic procedures, which was performed using advanced prototype named, SPORT Surgical System at Florida Hospital Nicholson Center. Titan Medical Inc. is engaged in the design, development, and commercialization of robotic surgical procedures for application in minimally invasive surgery. Single-port surgery is minimally invasive surgery performed through a single port or incision. Although it is difficult without robotic assistance, it is highly beneficial, due to involvement of fewer ports, low complications, and rapid recovery. Moreover SPORT Surgical System is employed with capabilities to become valuable tool for robotic surgeons to perform single port surgery.

Such advancement in robotic assisted surgery enables the surgeons to perform complex operation in more precise way than conventional surgery, adding to the benefits such as, less blood loss, significantly less pain, lower risk of infection, shorter hospital stay, low recovery time, and better clinical outcome, which is expected to drive the growth of urology surgical instruments market in near future.

Some of the key players operating in the urology surgical instruments market includes Millennium Surgical Corp, Maxer Medizintechnik GmbH, Olympus Corporation, Boston Scientific Corporation, Medtronic plc, Teleflex Incorporated, Richard Wolf GmbH, Coloplast A/S, CONMED Corporation, STRYKER CORPORATION, CooperSurgical Inc., and COOK MEDICAL LLC.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Endoscopy Device Market, By Product Type, End User - Industry Insights, Trends, Outlook and Opportunity Analysis, 2025

Endoscopy devices are minimally-invasive diagnostic medical devices used to assess the internal organs of the body. Endoscopy devices are used to investigate unusual symptoms and perform certain types of surgery. An endoscopy device has a flexible tube with an attached camera, which allows the doctor to view potential threats without a large incision. Therapeutic endoscopy devices are modified endoscopes with surgical instruments attached to them to carry surgeries to remove kidney stones, fibroids. The simplicity of the procedure with minimal post operation complications makes it the most preferred and pursued procedure in surgery and diagnostics. The diverse applications of endoscopes to diagnose and treat various diseases has increased the adoption of flexible endoscopes across different healthcare settings. These devices include operative devices and visualization systems, which gives direct insight of the organs for efficient treatment, unlike other medical imaging devices.

Request to download and view Sample Report: https://www.coherentmarketinsights.com/insight/request-sample/442

Increasing prevalence of chronic diseases in the elderly population will boost the endoscopy device market

According to the World Health Organization in 2011, the world's population aged 60 years will double from 11% in 2000 to 22% by 2050. A central factor that boosts the endoscopy device market is the increase in number of elderly people prone to cancer, orthopedic, ophthalmic gastrointestinal diseases. With the constant increase in the elderly people, age-linked ailments are expected to escalate sharply, thus driving the demand and consumption of endoscopy devices. Also, endoscopy assures low-risk procedures and are easily covered by health insurance. Additionally, high prevalence of diseases requiring endoscopy for diagnosis and treatment, rising geriatric population, technological advancements, FDA approvals, reimbursement policies are the other factors driving the endoscopy device market.

Visualization systems segment holds the lion share in the endoscopy device market

The global endoscopy device market is segmented on the basis of product type, applications, end user and geography.

On the basis of product type, the global endoscopy equipment market is segmented into:

• Endoscopes
• Rigid Endoscopes
• Flexible Endoscopes
• Capsule Endoscopes
• Surgical Endoscopes
• Robot-assisted Endoscopes

On the basis of applications, global endoscopy equipment market is segmented into:

• Gastrointestinal Endoscopy
• Gynecology Endoscopy
• Urology Endoscopy
• Bronchoscopy
• Laryngoscopy
• Neuroendoscopy
• Others

On the basis of end user, global endoscopy equipment market is segmented into:

• Hospitals
• Ambulatory Surgical Centers
• Clinics
• Others

The advanced 3D imaging gives depth perception and is expected to dominate North Americanendoscopy equipment market

Regional segmentation of the global endoscopy equipment market by Coherent Market Insights comprises North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. According to the World Journal of Gastrointestinal Endoscopy in 2016, 7 million people in the U.S. have symptoms of Gastroesophageal Reflux Disorder (GERD) and is expected to reach around 9 million by 2025. North America has therefore dominated the global endoscopy equipment market with the increasing prevalence of diseases and approved government grants.  Europe is likely to witness surging demand as a result of rapidly aging population, increased obesity rates, growing incidence of associated disease technological advancements and improved reimbursement status. According to the Journal of Neurogastroenterology in 2011, the prevalence of endoscopic reflux esophagitis in East Asia was 6% in 2005 which has increased to 15% in 2015. Therefore, increasing affluence and number of private hospitals, expansion to rural healthcare facilities play an important role in boosting the demand in China and India in the Asian market.

Browse Research Report At: https://www.coherentmarketinsights.com/ongoing-insight/endoscopy-device-market-442

Robot-assisted endoscopic devices are expected to increase in demand in the future

The key players in the global endoscopic devices market include Artherx Inc., Boston Scientific Corporation, Conmed Corporation. Covidien has the largest market for capsule endoscopy due to the increased preference amongst physicians globally. Other vendors include Olympus Corporation, Ethicon, Karl Storz GmbH, Fujifilm Holding Corporation, Richard Wolf GmbH.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Anesthesia Machines Market, By Product Type, End User - Industry Insights, Trends, Outlook and Opportunity Analysis, 2025

Anesthesia is a practice of controlling the pain or other sensation during the time of surgery and other procedures with or without the loss of consciousness. It also helps in controlling the breathing, blood flow, blood pressure, and heart rate and rhythm.  There are four different types of anesthesia that includes local, general, regional and dissociative. Anesthesia machines are used by the professionals to support the administration of anesthesia. These machines deliver precisely known but variable gas mixtures, which are then delivered to the breathing systems. These gases are administered with the help of oxygen mask. Patients are administered a mixture of oxygen, nitrous oxide and other gases that are regulated by anesthetic machines. Over the years, anesthesia machines have evolved from a simple pneumatic device to a complex array of electrical, mechanical and computer controlled systems for patient safety and user convenience.

Request to download and view Sample Report: https://www.coherentmarketinsights.com/insight/request-sample/432

The anesthetic machine comprises three pressure systems:

• A high pressure system that collects gases at cylinder pressure
• An intermediate pressure system that delivers gases to flow meters.
• A low pressure system that carries gases from the flow meters to the machine outlet

The advanced anesthetic machines comprise of better features compared to conventional machines in terms of proper ventilation techniques, accurate monitoring features, inhaled agent delivery, low flow and closed loop anesthesia.

Latest machines launched in 2015 and 2016, in the global anesthesia machines market, such as the Venor Xenon workstation (Chirana Medical), Felix Dual (Air Liquide Medical system) and Tangens 2C (EKU Electronics), have the advanced features to recycle and reuse xenon, making it cost effective and helping professionals to use xenon based anesthesia simultaneously with conventional nitrous oxide based anesthesia.

Anesthesia machines market taxonomy:

On the basis of technology, the anesthesia machines market is classified into:

• Intermittent
• Continuous

The continuous type anesthetic machines are majorly used in the market as they allow gas flow during inspiration and expiration.

On the basis of product type, the anesthesia machines market is classified into:

• Portable Anesthesia Machines
• Stand Alone Anesthesia Machines

On the basis of end user, the market is classified into:

• Hospitals
• Clinic
• Ambulatory Surgical Centers

Geriatric population is highly susceptible to diseases and thus, account for a large proportion of the global patient population. According to United Nations, Department of Economic and Social Affairs, Population Division,  the global population aged 60 & above increased by 68% in urban areas and by 25% in the rural areas between 2000 and 2015. This rise in geriatric population scenario is shaping favorably for sustained growth of anesthesia machines market over the following decade. Furthermore, the rise in surgical procedures and increasing accident and trauma cases serve as the driving factor for the growth of the market. According to World Health Organization, around 266.2 to 359.5 million surgeries were performed in 2012, which represents a 38% increase over the previous 8 years.

The continuous improvements in healthcare sector and adoption of minimal invasive surgeries are favoring the growth of anesthesia machines market.  By geography, North America holds the major share due to advanced healthcare infrastructure and is followed by Europe and Asia Pacific, respectively. According to a study published in NCBI in 2014, there has been a significant increase of 31.3% in minimal invasive surgical procedures from 2007 to 2012.  Among Asian countries, China and India are shown to experience a considerable market growth due to the large patient pool and increasing number of hospitals. As per Association for Safe International Road Travel (ASIRT), over 90% of the total road accidents occurs in low and middle-income countries.

Browse Research Report At: https://www.coherentmarketinsights.com/ongoing-insight/anesthesia-machines-market-432

However, high cost of the anesthetic machines is one of the barrier to this market. Also, there exists a refurbished and used market for anesthetic machines which can serve as a restraining factor for the global anesthesia machines market.

Major players in the anesthesia machines market are Smiths medical, GE Healthcare, Spacelabs Healthcare, Covidien, Dragerwerk, Aeonmed, Heyer Medical, Oricare, Oricare, Supera Anesthesia Innovations, Dameca A•S, Carefusion Corporation and KGaA, Getinge Group.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Vascular Grafts Market, By Product Type, End User - Industry Insights, Trends, Outlook and Opportunity Analysis, 2025

Vascular Grafts are medical devices used to bypass the infected or diseased blood vessels. Vascular grafts are required to replace injured blood vessels, veins, and arteries and to substitute hard blood vessels or valves. Blood flow is redirected from one place to another by introducing a graft with the help of surgical reconstruction process. These grafts can be synthetic, semi-synthetic or taken from the patient’s body.

Vascular grafts are majorly used in treatment of cardiovascular diseases by surgical procedures such as bypass grafting. The graft is taken from the patient’s body and surgically inserted at the required site to bypass the damaged or diseased blood vessels. Factors such as smoking, high blood pressure, atherosclerosis, and diabetes lead to chronic heart diseases in turn increasing the demand for effective and life sustaining treatment. Bypass surgeries are performed in patients suffering from coronary artery diseases, angina pectoris, heart attack, atherosclerosis, diabetes, and multiple heart artery blockages.

Request to download and view Sample Report: https://www.coherentmarketinsights.com/insight/request-sample/1075

Rising prevalence of coronary artery diseases is expected to boost the growth of vascular grafts market

According to Centers for Disease Control and Prevention (CDC) in 2016, approximately 8.5 million people in the U.S. had peripheral arterial diseases with healthcare costs accounting for US$ 21 billion annually. Increasing requirement for treatment with bypass surgeries is expected to boost the growth of vascular grafts market.

Age is also a risk factor for coronary artery diseases. In 2015, around 44 million people over age 60 were suffering from coronary artery diseases in the U.S. according to American Heart Association (AHA). Furthermore, according to the AHA in 2017, around 92 million American adults are suffering from cardiovascular diseases, which is expected to fuel the growth of vascular grafts market.

According to National Health Service (NHS) in England, around 20,000 coronary bypass surgeries are carried out annually, which is expected to rise due to changing lifestyle habits leading to chronic cardiovascular diseases, in turn rising demand for the treatment.

Factors such as increasing geriatric population, increasing diabetes prevalence leading to heart diseases, and unhealthy lifestyles are expected to increase the prevalence of cardiovascular diseases, in turn boosting the growth of bypass surgeries and vascular grafts market. Complications in the bypass surgery such as bleeding, arrhythmias and stroke are the restraining factors for the market.

Vascular Grafts Market Taxonomy

Advancements in graft materials and surgery techniques such as off-pump CABG surgery are driving the growth of vascular grafts market. The global vascular grafts market is segmented on the basis of product type, application, material, end user, and geography.

On the basis of product type, the global vascular grafts market is segmented into:

• Endovascular Stent Graft
• Hemodialysis Access Graft
• Bypass Graft
• Peripheral Vascular Graft
• Others

On the basis of application, the global vascular grafts market is segmented into:

• Coronary Artery Disease
• Vascular Occlusion
• Renal Failure
• Aneurysm
• Others

On the basis of material, the global vascular grafts market is segmented into:

• Synthetic
• Teflon
• Nylon
• Dacron
• Others
• Biological
• Bovine Vein
• Saphenous Vein
• Others
• Biosynthetic
• Ovine Collagen with Polyester
• Others

On the basis of end user, the global vascular grafts market is segmented into:

• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics
• Others

Browse Research Report At: https://www.coherentmarketinsights.com/ongoing-insight/vascular-grafts-market-1075

Regional segmentation of the vascular grafts market by Coherent Market Insights comprises North America, Europe, Latin America, Asia Pacific, Middle East, and Africa. North America region is expected to dominate the market due to increasing prevalence of lifestyle diseases especially cardiovascular disease, skilled medical professionals coupled with insurance facilities, and increasing geriatric population, which is at a high risk of cardiovascular diseases. Asia Pacific region is expected to show the highest growth rate in the market during the forecast period due to factors such as improving healthcare facilities, increasing awareness towards heart diseases, and increasing diabetes prevalence. In India vascular grafts market is expected to show highest growth rate due to factors such as large customer base, rising awareness through government programs such as World Heart Day, and increasing life expectancy. In 2015, around 30 million people were suffering from cardiovascular diseases in India and the number is expected to increase over the forecast period.

Key players operating in the vascular grafts market include Medtronic Plc., Vascutek Ltd, W.L. Gore & Associates, Inc., B. Braun Melsungen AG, Terumo Medical Corporation, Artegraft, Bard Peripheral Vascular Inc., LeMaitre Vascular Inc., and Heart Medical Europe BV.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Pressure Bandages Market, By Product, Technology, and End User - Opportunity Analysis, 2025

Leg ulcer is one of the most common ailments among the adult population. It is a fault in the skin of the lower portion of the leg with slow or no healing propensity of a wound over a period of 3 months. Simply put, a leg ulcer is a rupture in the leg skin, which permits bacteria and air to permeate into the fundamental or underlying tissue. Leg ulcers are usually caused by injury that breaks the skin.

Request to download and view Sample Report: https://www.coherentmarketinsights.com/insight/request-sample/228

The management of chronic leg ulceration include a variety of compression therapies such as garments such as bandages and stockings and intermittent pneumatic. Pressure bandages falls under the category of compression garment that aids in faster healing and controlling infection of wounds, while prevention of excessive blood loss as well. Compression bandages also called pressure bandages, are a kind of field dressing used to apply pressure to a wound. These are usually wrapped around the wound and are then pulled tight to maximize the pressure applied in the area. Pressure bandages are usually used in situations where instantaneous first aid is necessary to protect one’s health. They are wrapped around the lower limb to apply a desired pressure that offers a degree of firmness directly to the wound. Pressure bandages are predominantly used for treating venous leg ulcers, swelling, oedema, sprains, and other lymphatic conditions.

One of the important factors is to apply the pressure bandage carefully or else it can lead to a several complications such as tourniquet negative effect and decrease blood pressure. The primary symptoms of leg ulcer are friable granulation, cramps in the calves, skin discolorations and dermatitis. Around 2 to 3 million people in the U.S. are identified with chronic wounds each year, according to the Wound Healing Society (a scientific group focused on wound healing). The rising prevalence of chronic leg ulcer will lead to an increase in demand for pressure bandages during the forecast period.

Pressure Bandages market Taxonomy

On the basis of product type, the global market is classified into:

• Long Stretch or Elastic Bandages
• Multi-component Multilayer Bandage Systems (MLBs)
• Short Stretch or Low-elasticity Bandages

On the basis of raw material, the global market is classified into:

• Cotton Fabric
• Latex
• Polymer
• Fiber

The elastic or long stretch bandages held a significant market share in the global pressure bandages market. High elasticity of over 100% and its high extensibility that can apply constant pressure to the wound directly, are some of the factors responsible for the dominance of the segment in the global pressure bandages industry. These pressure bandages are usually recommended for stationary patients who are incapable of activating their calf-muscle pump. Multi-component multilayer bandages act as an alternative to long elastic pressure bandages. They deliver constant and consistent compression for managing lower leg ulcers.

Growing prevalence of chronic leg ulcer and increase in the geriatric population will drive the overall pressure bandages market

An independent study available in Hindawi Publishing Corporation (a commercial publisher of technical, scientific, and medical literature) revealed that 1% of the overall adult population suffers from chronic leg ulceration and it affects 3.5% of people older than 65 years. North America accounted for the maximum share in the global pressure bandages market, followed by Asia Pacific. This is mainly attributed to high prevalence of chronic leg ulcers, presence of large number of manufacturers of pressure bandages, developed healthcare facilities, and increase in research related activities.

Browse Research Report At: https://www.coherentmarketinsights.com/ongoing-insight/pressure-bandages-market-228

The emerging economies of India and China in Asia Pacific hold enormous potential for growth of the market due to the presence of large elderly population, considerable growth in private & public hospitals and drug stores, growing per capita income coupled with growth in healthcare expenditure. This region is expected to grow at a maximum rate in the global pressure bandages market over the course of the forecast period.

Some of the companies operating in the pressure bandages market in the current scenario are BSN medical, 3M, Johnson & Johnson, Lohmann & Rauscher, Smith & Nephew, and Covidien. Some of the other companies operating in the market are Datt Mediproducts Private Limited, Moore Medical LLC, Mölnlycke Health Care, Dynamic Techno Medicals and Paul Hartmann Pty. Ltd.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Endoscope Reprocessing Device Market, By Product, Technology, and End User - Opportunity Analysis, 2025

Endoscope reprocessing devices are used in the healthcare settings for the reprocessing procedures of the endoscopes. The endoscope reprocessing devices are used to decontaminate the instruments and devices such as duodenoscopes, endoscope accessories, and others. Endoscope reprocessing devices are Class II devices cleared through the premarket notification by the Food and Drug Administration (FDA). The devices are designed to inhibit microorganisms in or on reusable endoscopes by exposing their outside surfaces and interior channels to chemical solutions. Moreover, the endoscope reprocessing devices reduce staff exposure hazards associated with aldehyde-based solutions, thus granting major safety advantage for the adoption and usage of endoscope reprocessing devices.

Request to download and view Sample Report: https://www.coherentmarketinsights.com/insight/request-sample/1010

Rising adoption of the innovative automated endoscope reprocessors in the healthcare settings to augment the growth of endoscope reprocessing market

The rise in adoption of endoscope reprocessors in hospitals for infection prevention and control and the emergence of automated endoscope reprocessors (AER) in the healthcare settings is expected to fuel the growth of the global endoscope reprocessing device market over the forecast period. The AERs can enhance the reliability and consistency of endoscope reprocessing by standardizing several important reprocessing steps, thereby reducing the possibility of human error. The use of AERs reduces exposure of personnel to harmful chemical germicides, thereby minimizing the health problems attributed to reprocessing of endoscopes. Moreover, rising government concerns pertaining to patient safety and strong healthcare infrastructure support are the factors contributing to rise in global endoscope reprocessing device market. For instance, in 2015, the Centers for Disease Control and Prevention (CDC) has asked the Healthcare Infection Control Practices Advisory Committee (HICPAC) to issue guidelines for the improvement of facility-level training to ensure competency for endoscope reprocessing devices.

However, higher cost associated with the chemicals and consumables, infection risks after endoscopic reprocessing procedures, and complications associated with automated endoscope reprocessors are some of the factors restraining the growth of the global endoscope reprocessing market.

Global Endoscope Reprocessing Device Market Taxonomy

The global endoscope reprocessing device market is segmented on the basis of product type, modality, end user, and geography.

On the basis of product type, the global endoscope reprocessing device market is segmented into:

• Ultrasonic washers
• Pasteurizers
• Washer-disinfectors
• Sterilizers
• Automated endoscope reprocessors (AERs)
• Single basin automated endoscopic reprocessors
• Double basin automated endoscopic reprocessors

On the basis of modality, the global endoscope reprocessing device market is segmented into:

• Stand- alone endoscopic reprocessors
• Bench top endoscopic reprocessors

On the basis of end user, the global endoscope reprocessing device market is segmented into:

• Hospitals
• Specialty Clinics
• Ambulatory Surgical Centers

Rising number of endoscopic procedures in North America is expected to dominate the endoscope reprocessing devices market

Regional segmentation of the endoscope reprocessing device market by Coherent Market Insights comprises North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America is expected to dominate the endoscope reprocessing device market with the factors attributed to larger number of endoscopic procedures. According to the American Society for Gastrointestinal Endoscopy, 2016, approximately 20 million gastro intestinal endoscopic procedures are performed annually in the U.S. with the transmission rate of infectious agents with an estimated frequency of 1 out of 1.8 million procedures. Asia Pacific is expected to witness a drastic growth in global endoscope reprocessing device market, owing to the enhanced competition with the presence of top manufacturers and ageing population susceptible to frequent medical check-ups, thus creating a positive impact on the endoscope reprocessing devices market.

Browse Research Report At: https://www.coherentmarketinsights.com/ongoing-insight/endoscope-reprocessing-device-market-1010

Launch of innovative automated reprocessing devices by the major players to accelerate the global endoscope reprocessing device market

The key players operating the endoscope reprocessing device market are STERIS Plc., Cilag GmbH International, Soluscope, ENDO-TECHNIK W.Griesat GmbH, Getinge AB, PENTAX Medical, Wassenburg Medical B.V., Steelco S.p.A., Medivators Inc., Johnson & Johnson, and Minntech Corp. The key players are mainly focused on product innovations and global expansion of the products to expand the market presence. For instance, the Getinge ED-FLOW AER (automated endoscope reprocessing) launched by Getinge Group in 2014, is the world's first true pass-through AER. The product two separate chambers and short cycles, which offers excellent capacity to reprocess 6 endoscopes per hour, providing solutions in large endoscopy departments.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Laboratory Filtration in Health Care Market, By Product, Technology, and End User - Opportunity Analysis, 2025

Filtration has a wide laboratory-scale applications as it is used in various fields, such as research laboratories, microbial analysis, discovery and development of drugs and vaccines, and virus removal. Laboratory filtration is used in sample preparation prior to the analysis by using an instrumental analytical method such HPLC/UHPLC. Laboratory filtration is also used in instrument protection. For instance, hydrophobic filter in the pipette. Furthermore, analytical filtration are used in water quality testing to determine the microbial content of samples. Considering the wide application for laboratory filtration products, increase in the usage of analytical instruments, and introduction of advance filters is expected to drive the growth of laboratory filtration in healthcare market during the forecast period.

Request to download and view Sample Report: https://www.coherentmarketinsights.com/insight/request-sample/1015

Global Laboratory Filtration in Healthcare Market Taxonomy

The global laboratory filtration in healthcare market is segmented on the basis of product, technology, and end user

By Product

• Filtration Assemblies
  • Microfiltration Assemblies
  • Reverse Osmosis Assemblies
  • Ultrafiltration Assemblies
  • Vacuum Filtration Assemblies
  • Others
• Filtration Media
• Filter Papers
• Cellulose Filter Papers
• Glass Microfiber Filter Papers
• Quartz Filter Papers
• Membrane Filters
• Syringe Filters
• Syringeless Filters
• Capsule Filters
• Filtration Microplates
• Others
• Filtration Accessories
  • Filter Holders
  • Filter Funnels
  • Filter Dispensers
  • Filter Flasks
  • Filter Housings
  • Cartridges
  • Vacuum Pumps
  • Seals
  • Other Accessories

By Technology:

• Microfiltration
• Ultrafiltration
• Reverse Osmosis
• Vacuum Filtration
• Nano filtration

By End User:

• Pharmaceutical & Biopharmaceutical Companies
• Academic & Research Institutes
• Hospital & Diagnostic Laboratories

Browse Research Report At: https://www.coherentmarketinsights.com/ongoing-insight/laboratory-filtration-in-health-care-market-1015

Technological advancement is expected to boost the growth of the laboratory filtration in healthcare market

The laboratory filtration market has witnessed new product launches and innovative technologies. The technological advanced product provides high reliability and throughput as compared to conventional methods. For instance, Merck KGaA Durapore 0.22 µm hydrophilic Polyvinylidene fluoride (PVDF) membranes is used in endotoxins removal and is designed for sterile filtration. Durapore also provides high protein recovery with minimal loss of valuable product. Durapore is also used for filtration of lipids in small and large volume system. Reverse Osmosis systems is an another technique that provides various benefits and widely used in laboratories as it is a physical process, which does not uses regenerating chemicals and hence, provides excellent defense against viruses, pyrogens, and bacteria making reverse osmosis systems cost-effective technique. Technological advancements in filtration products have resulted in an increase in the adoption rate, which in turn is expected to result in growth of the laboratory filtration in healthcare market.

Increasing focus towards the development of biopharmaceutical molecules and the rising application of filtration techniques are expected to contribute for the growth of the laboratory filtration in healthcare market

Companies are developing advance products for the treatment of various diseases and to develop this molecules wide range of laboratory filters are used in clinical and research institutes, which are expected to increase the demand for laboratory filtration. For instance, Ultrafiltration (UF) are widely used for the removal of suspended solids like bacteria, high-molecular-weight molecules, and endotoxin. The robust ultrafiltration processes plays crucial role in the development of bio-pharmaceutical products. Cellulose nitrate membrane filters are prepared by the reaction of nitric acid and cellulose. This filters are widely used for the filtration of peptides and proteins in molecular biology. Thus, increasing use of filtration technique in research and development of molecules is expected to support the growth of the laboratory filtration in healthcare market.

The key players operating in the global laboratory filtration in healthcare market include Merck Millipore, 3M Purification, Inc., Thermo Fisher Scientific, Inc., Sigma-Aldrich, Pall Corporation, Cantel Medical Corp, Sartorius Group, Macherey-Nagel Gmbh & Co., and GE Healthcare.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.